Cargando…
Detecting truly clonal alterations from multi-region profiling of tumours
Modern cancer therapies aim at targeting tumour-specific alterations, such as mutations or neo-antigens, and maximal treatment efficacy requires that targeted alterations are present in all tumour cells. Currently, treatment decisions are based on one or a few samples per tumour, creating uncertaint...
Autores principales: | Werner, Benjamin, Traulsen, Arne, Sottoriva, Andrea, Dingli, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366809/ https://www.ncbi.nlm.nih.gov/pubmed/28344344 http://dx.doi.org/10.1038/srep44991 |
Ejemplares similares
-
How many samples are needed to infer truly clonal mutations from heterogenous tumours?
por: Opasic, Luka, et al.
Publicado: (2019) -
A deterministic model for the occurrence and dynamics of multiple mutations in hierarchically organized tissues
por: Werner, Benjamin, et al.
Publicado: (2013) -
Spatially constrained tumour growth affects the patterns of clonal selection and neutral drift in cancer genomic data
por: Chkhaidze, Ketevan, et al.
Publicado: (2019) -
Should tissue structure suppress or amplify selection to minimize cancer risk?
por: Hindersin, Laura, et al.
Publicado: (2016) -
Replicative cellular age distributions in compartmentalized tissues
por: Böttcher, Marvin A., et al.
Publicado: (2018)